Standard Biotools (LAB) Capital Expenditures Growth (5y) (2015 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.43 Bn | 221.37 Bn | 8.34 Bn |
| 2 | Danaher | 144.26 Bn | 139.91 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.88 Bn | 39.12 Bn | 1.04 Bn |
| 4 | Illumina | 30.92 Bn | 29.75 Bn | 770.00 Mn |
| 5 | Revvity | 13.86 Bn | 12.84 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.74 Bn | 8.18 Bn | 112.50 Mn |
| 10 | Standard Biotools | 283.04 Mn | -193.68 Mn | 10.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -50.08% |
| Mar 31, 2026 | -39.31% |
| Dec 31, 2025 | -46.35% |
| Sep 30, 2025 | 21.18% |
| Jun 30, 2025 | 24.10% |
| Mar 31, 2025 | 37.45% |
| Dec 31, 2024 | 46.57% |
| Sep 30, 2024 | 10.87% |
| Jun 30, 2024 | 35.83% |
| Mar 31, 2024 | 24.04% |
| Dec 31, 2023 | 31.28% |
| Sep 30, 2023 | 35.52% |
| Jun 30, 2023 | 61.19% |
| Mar 31, 2023 | 67.33% |
| Dec 31, 2022 | 33.51% |
| Sep 30, 2022 | 17.94% |
| Jun 30, 2022 | 45.88% |
| Mar 31, 2022 | 4.64% |
| Dec 31, 2021 | -6.35% |
| Sep 30, 2021 | 49.59% |